BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 12924248)

  • 1. [Antineutrophil cytoplasmic antibody(ANCA)].
    Yoshida M
    Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
    Gross WL; Reinhold-Keller E
    Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H; Ozaki S
    Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
    Zhang X; Jiang M; Chui J; Wang H; Ma J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
    Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
    Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.
    Vassilopoulos D; Niles JL; Villa-Forte A; Arroliga AC; Sullivan EJ; Merkel PA; Hoffman GS
    Arthritis Rheum; 2003 Apr; 49(2):151-5. PubMed ID: 12687504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
    Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
    Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
    Gal AA; Velasquez A
    Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of anti-neutrophil cytoplasmic antibody and pathogenetic role of adhesion molecules for Wegener's granulomatosis].
    Takizawa M
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):517-29. PubMed ID: 8809575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.